Merck has bought numerous other cancer treatments over the last 10 years repeatedly passing over NWBO. They know all the data from the SPORE/UCLA trials and still bought two other cancer treatments in the last 2 years and NOT NWBO. There has been a single deal between a BP and an OTC biotech drug company. It's not going to happen.
NWBO has no clinical evidence for any other cancer than GBM. Regulators don't approve drugs without specific evidence in for the specific indication.
20+ years in the biopharma world including launch team for the most successful launch of it's time.
Market Data 
Markets 
AI
